Categories AP and Reuters AstraZeneca’s Tagrisso slashes death risk in certain post-surgery lung cancer patients reut.rs/43mOzqK Post author By Mike Nova Post date June 4, 2023 AstraZeneca’s Tagrisso slashes death risk in certain post-surgery lung cancer patients reut.rs/43mOzqK ← 14 dead, 5 missing in southwest China landslide → Far-left protesters clash with German police in Leipzig after trial verdict